Sharon Giese MD is a board-certified plastic surgeon and fellowship trained in aesthetic surgery.  She started doing fat research over 20 years ago while at Georgetown University and collaborated with the NIH.  There she showed large volume liposuction can be incorporated into a successful weight loss program with health benefits.  Later she supported a rat lab at Yale University further studying fat transplantation and the important factors it confers.

Today she is revisiting the world of weight loss with semaglutide, a naturally occurring peptide.  It is the active ingredient in Wegovy™ and Ozempic™, that are FDA approved for weight loss in obese patients.  Dr. Giese’s recent, ground-breaking, study proved semaglutide is highly effective for elective weight loss in normal and overweight people as well and there are health benefits to staying closer to your low weight as an adult.  It is not beneficial to gain weight as you age and if that happens, address it immediately.

Elective Weight Loss™ encourages a healthier lifestyle and promotes longevity.  Aesthetic wellness has never been more advanced particularly when combined with testosterone pellets for bioidentical hormone replacement and other regenerative  medicine therapies.

Surgical rejuvenation cannot be replaced when maximum improvement is expected.  Her signature procedures are the Natural Lift, Breast & Cleavage Lift, Short Scar face and Neck lifts and Circumferential Liposuction.

For more information about Sharon Giese MD and her signature treatments, please visit sharongiesemd.com

Education

  • Vassar College; Poughkeepsie, NY
  • Northwestern Medical School; Chicago, IL
  • Stanford University; Stanford, CA: Surgical Training
  • Stanford University; Stanford, CA: Plastic Surgery Training
  • Georgetown University; Washington DC: Fellowship In Breast and Cosmetic Surgery
  • Research Affiliated with National Institutes of Health (NIH): Northwestern University, Stanford University, Georgetown University and Columbia University